Short Interest in ReWalk Robotics Ltd. (NASDAQ:LFWD) Increases By 214.2%

ReWalk Robotics Ltd. (NASDAQ:LFWDGet Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,510,000 shares, a growth of 214.2% from the February 28th total of 798,900 shares. Based on an average daily volume of 2,450,000 shares, the days-to-cover ratio is currently 1.0 days. Approximately 26.8% of the shares of the company are sold short.

ReWalk Robotics Stock Down 4.8 %

Shares of ReWalk Robotics stock opened at $1.79 on Friday. The firm’s 50-day moving average price is $1.67 and its two-hundred day moving average price is $2.09. The company has a market capitalization of $19.03 million, a price-to-earnings ratio of -0.72 and a beta of 1.73. ReWalk Robotics has a 12-month low of $1.25 and a 12-month high of $6.00.

ReWalk Robotics (NASDAQ:LFWDGet Free Report) last announced its quarterly earnings data on Friday, March 7th. The company reported ($1.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.53). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The firm had revenue of $7.55 million during the quarter, compared to the consensus estimate of $7.30 million. On average, sell-side analysts expect that ReWalk Robotics will post -1.78 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on LFWD. Lake Street Capital decreased their target price on shares of ReWalk Robotics from $4.50 to $4.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th. HC Wainwright restated a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a research note on Tuesday, March 11th. Finally, Laidlaw started coverage on ReWalk Robotics in a report on Monday, February 10th. They issued a “buy” rating and a $10.00 price objective for the company.

View Our Latest Analysis on ReWalk Robotics

Insider Activity

In other news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $3.36, for a total value of $1,282,431.36. Following the completion of the sale, the insider now owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. The trade was a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.50% of the stock is owned by company insiders.

About ReWalk Robotics

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.

Featured Articles

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.